trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['bcsm']
 great study!!!
where will you place saci when tdxd is approved in low her2/er+ setting? #asco2022 #bcsm
Director, SUNY Upstate Cancer Center at Community Campus, Fellowship Program Director, Medical Oncologist #Upstatecancer, Mom to 2 lovely girls and wife